A Comparative Study of Indobufen and Aspirin in Patients With Coronary Atherosclerosis
NCT05105750
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Coronary Atherosclerosis
Interventions
DRUG:
aspirin 100 mg/d
DRUG:
indobufen 200 mg bid
Sponsor
The First Affiliated Hospital with Nanjing Medical University